These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 28842930)

  • 1. Medication-Assisted Opioid Treatment Prescribers in Federally Qualified Health Centers: Capacity Lags in Rural Areas.
    Jones EB
    J Rural Health; 2018 Dec; 34(1):14-22. PubMed ID: 28842930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Where Is Buprenorphine Dispensed to Treat Opioid Use Disorders? The Role of Private Offices, Opioid Treatment Programs, and Substance Abuse Treatment Facilities in Urban and Rural Counties.
    Stein BD; Pacula RL; Gordon AJ; Burns RM; Leslie DL; Sorbero MJ; Bauhoff S; Mandell TW; Dick AW
    Milbank Q; 2015 Sep; 93(3):561-83. PubMed ID: 26350930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. U.S. trends in the supply of providers with a waiver to prescribe buprenorphine for opioid use disorder in 2016 and 2018.
    Ghertner R
    Drug Alcohol Depend; 2019 Nov; 204():107527. PubMed ID: 31525570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in Availability and Use of Medications for Opioid Use Disorder in Residential Treatment Settings in the United States.
    Huhn AS; Hobelmann JG; Strickland JC; Oyler GA; Bergeria CL; Umbricht A; Dunn KE
    JAMA Netw Open; 2020 Feb; 3(2):e1920843. PubMed ID: 32031650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescribing Practices of Rural Physicians Waivered to Prescribe Buprenorphine.
    Andrilla CHA; Coulthard C; Patterson DG
    Am J Prev Med; 2018 Jun; 54(6 Suppl 3):S208-S214. PubMed ID: 29779544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expanding access to buprenorphine treatment in rural areas with the use of telemedicine.
    Weintraub E; Greenblatt AD; Chang J; Himelhoch S; Welsh C
    Am J Addict; 2018 Dec; 27(8):612-617. PubMed ID: 30265425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of barriers to adoption of buprenorphine maintenance therapy by family physicians.
    DeFlavio JR; Rolin SA; Nordstrom BR; Kazal LA
    Rural Remote Health; 2015; 15():3019. PubMed ID: 25651434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Harm Reduction Agencies as a Potential Site for Buprenorphine Treatment.
    Fox AD; Chamberlain A; Frost T; Cunningham CO
    Subst Abus; 2015; 36(2):155-60. PubMed ID: 25837290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Federally Qualified Health Centers Can Expand Rural Access to Buprenorphine for Opioid Use Disorder in Arizona.
    Brady BR; Gildersleeve R; Koch BD; Campos-Outcalt DE; Derksen DJ
    Health Serv Insights; 2021; 14():11786329211037502. PubMed ID: 34408434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of the availability of hepatitis C testing services in opioid treatment programs: results from a national study.
    Frimpong JA; D'Aunno T; Jiang L
    Am J Public Health; 2014 Jun; 104(6):e75-82. PubMed ID: 24825236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Office-Based Opioid Treatment with Buprenorphine (OBOT-B): Statewide Implementation of the Massachusetts Collaborative Care Model in Community Health Centers.
    LaBelle CT; Han SC; Bergeron A; Samet JH
    J Subst Abuse Treat; 2016 Jan; 60():6-13. PubMed ID: 26233698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Addiction Treatment Capacity in Health Centers: The Role of Medicaid Reimbursement and Targeted Grant Funding.
    Jones EB; Staab EM; Wan W; Quinn MT; Schaefer C; Gedeon S; Campbell A; Chin MH; Laiteerapong N
    Psychiatr Serv; 2020 Jul; 71(7):684-690. PubMed ID: 32438889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Buprenorphine maintenance treatment retention improves nationally recommended preventive primary care screenings when integrated into urban federally qualified health centers.
    Haddad MS; Zelenev A; Altice FL
    J Urban Health; 2015 Feb; 92(1):193-213. PubMed ID: 25550126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rural substance use treatment centers in the United States: an assessment of treatment quality by location.
    Bond Edmond M; Aletraris L; Roman PM
    Am J Drug Alcohol Abuse; 2015; 41(5):449-57. PubMed ID: 26337202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of federally funded health centers in serving the rural population.
    Regan J; Schempf AH; Yoon J; Politzer RM
    J Rural Health; 2003; 19(2):117-24; discussion 115-6. PubMed ID: 12696847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perceived Barriers and Facilitators to Providing Methadone Maintenance Treatment Among Rural Community Pharmacists in Southwestern Ontario.
    Fonseca J; Chang A; Chang F
    J Rural Health; 2018 Dec; 34(1):23-30. PubMed ID: 28872697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of methods for measuring spatial access to health care.
    Drake C; Nagy D; Nguyen T; Kraemer KL; Mair C; Wallace D; Donohue J
    Health Serv Res; 2021 Oct; 56(5):777-787. PubMed ID: 34250592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determining spatial access to opioid use disorder treatment and emergency medical services in New Hampshire.
    Cao Y; Stewart K; Wish E; Artigiani E; Sorg MH
    J Subst Abuse Treat; 2019 Jun; 101():55-66. PubMed ID: 31174714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing Differences in the Availability of Opioid Addiction Therapy Options: Rural Versus Urban and American Indian Reservation Versus Nonreservation.
    Hirchak KA; Murphy SM
    J Rural Health; 2017 Jan; 33(1):102-109. PubMed ID: 26987797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of U.S. substance abuse treatment facilities adopting buprenorphine in its initial stage of availability.
    Koch AL; Arfken CL; Schuster CR
    Drug Alcohol Depend; 2006 Jul; 83(3):274-8. PubMed ID: 16413146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.